Outcomes of Coronary Artery Bypass Grafting in Israeli Jews and Arabs

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06766123

Enrollment

7067

Registered

2025-01-09

Start date

2009-01-01

Completion date

2023-12-31

Last updated

2025-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CABG, Ethnic Group

Brief summary

Retrospective study of adult patients with multivessel disease undergoing isolated CABG in three centers between January 1st, 2009, and December 31st, 2023. The primary outcome was a composite of major adverse cardiac and cerebrovascular events (MACCE). Patients were grouped according to their ethnic origin, Arabs and Jews.

Interventions

PROCEDURECABG

All patients underwent isolated CABG and retrospectively followed to asses ethnic disparities

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* isolated CABG

Exclusion criteria

* members of different HMO

Design outcomes

Primary

Measure	Time frame
MACCE	through study completion, a median of 78 months

Secondary

Measure	Time frame
Mortality	through study completion, a median of 78 months
MI	through study completion, a median of 78 months
CVA	through study completion, a median of 78 months
repeat revascularization	through study completion, a median of 78 months
utilization of multi-arterial grafting	through study completion, a median of 78 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026